Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis.
Indoleamine 2,3-dioxygenase (IDO) is the first and rate-limiting step along the kynurenine pathway and is thought to play a key role in immune homeostasis through depletion of tryptophan and accumulation of kynurenines. In this review we summarize recent research into the possibility of harnessing t...
Main Author: | |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|